63 related articles for article (PubMed ID: 21309746)
1. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL
Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746
[TBL] [Abstract][Full Text] [Related]
2. Serum copeptin and NT-proBNP is associated with central aortic stiffness and flow hemodynamics in adolescents with type 1 diabetes: A pilot study.
Melena I; Bjornstad P; Schäfer M; Hunter KS; Barker AJ; Baumgartner A; Chung L; Wiromrat P; Truong U; Reusch JEB; Nadeau KJ
J Diabetes Complications; 2021 May; 35(5):107883. PubMed ID: 33712333
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.
Winther JA; Brynildsen J; Høiseth AD; Strand H; Følling I; Christensen G; Nygård S; Røsjø H; Omland T
Respir Res; 2017 Nov; 18(1):184. PubMed ID: 29100503
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction.
Kim CH; Lee SH; Kim HK; Kim MC; Kim JH; Hong YJ; Ahn YK; Jeong MH; Hur SH; Kim DI; Chang K; Park HS; Bae JW; Jeong JO; Park YH; Yun KH; Yoon CH; Kim Y; Hwang JY; Kim HS; Choi KH; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Lee JM;
Circ J; 2024 Apr; ():. PubMed ID: 38599833
[TBL] [Abstract][Full Text] [Related]
5. Circulating Matrix Metalloproteinase-28 Levels Are Related to GRACE Scores and Short-Term Outcomes in Patients with Acute Myocardial Infarction.
Zhou K; Li Y; Xu Y; Guo R
Biomed Res Int; 2020; 2020():9206703. PubMed ID: 32596395
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a hybrid risk model to predict major cardiac adverse events in patients with non-ST-elevation acute coronary syndromes.
Zhang N; Liu W
Exp Ther Med; 2016 Jul; 12(1):427-432. PubMed ID: 27347073
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies.
Montellano FA; Rücker V; Ungethüm K; Penalba A; Hotter B; Giralt M; Wiedmann S; Mackenrodt D; Morbach C; Frantz S; Störk S; Whiteley WN; Kleinschnitz C; Meisel A; Montaner J; Haeusler KG; Heuschmann PU
Eur Stroke J; 2024 May; ():23969873241250272. PubMed ID: 38711254
[TBL] [Abstract][Full Text] [Related]
8. Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model.
Boeckel JN; Oppermann J; Anadol R; Fichtlscherer S; Zeiher AM; Keller T
Sci Rep; 2016 Feb; 6():20812. PubMed ID: 26864512
[TBL] [Abstract][Full Text] [Related]
9. Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker.
North WG
Onco Targets Ther; 2023; 16():973-982. PubMed ID: 38021449
[TBL] [Abstract][Full Text] [Related]
10. Copeptin and the prognosis of patients with coronary artery disease: a meta-analysis.
Shi Z; Qian C
Ir J Med Sci; 2023 Oct; 192(5):2129-2141. PubMed ID: 36719516
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.
Omran F; Kyrou I; Osman F; Lim VG; Randeva HS; Chatha K
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628490
[TBL] [Abstract][Full Text] [Related]
12. Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients.
Szarpak L; Lapinski M; Gasecka A; Pruc M; Drela WL; Koda M; Denegri A; Peacock FW; Jaguszewski MJ; Filipiak KJ
J Cardiovasc Dev Dis; 2021 Dec; 9(1):. PubMed ID: 35050216
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of copeptin in patients with acute myocardial infarction treated with percutaneous coronary intervention: a prospective cohort study.
Roczek-Janowska M; Kacprzak M; Dzieciol M; Zielinska M; Chizynski K
J Thorac Dis; 2021 Jul; 13(7):4094-4103. PubMed ID: 34422339
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of copeptin in patients with acute coronary syndrome: A systematic review and meta-analysis.
Lu J; Wang S; He G; Wang Y
PLoS One; 2020; 15(8):e0238288. PubMed ID: 32857795
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: a prospective observational study.
Aarsetøy R; Omland T; Røsjø H; Strand H; Lindner T; Aarsetøy H; Staines H; Nilsen DWT
BMC Cardiovasc Disord; 2020 Aug; 20(1):382. PubMed ID: 32838754
[TBL] [Abstract][Full Text] [Related]
16. Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients With Documented Ventricular Fibrillation.
Aarsetøy R; Aarsetøy H; Hagve TA; Strand H; Staines H; Nilsen DWT
Front Cardiovasc Med; 2018; 5():44. PubMed ID: 29930943
[TBL] [Abstract][Full Text] [Related]
17. Cardiac rehabilitation in patients with ST-segment elevation myocardial infarction: can its failure be predicted?
Irzmański R; Kapusta J; Obrębska-Stefaniak A; Urzędowicz B; Kowalski J
Ther Adv Cardiovasc Dis; 2017 Jul; 11(7):177-184. PubMed ID: 28553755
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in high-risk patients with non-ST-segment elevation myocardial infarction.
Cohen M
J Thromb Thrombolysis; 2016 Apr; 41(3):464-74. PubMed ID: 26001907
[TBL] [Abstract][Full Text] [Related]
19. Copeptin testing in acute myocardial infarction: ready for routine use?
Reinstadler SJ; Klug G; Feistritzer HJ; Metzler B; Mair J
Dis Markers; 2015; 2015():614145. PubMed ID: 25960596
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
